According to research in transgenic and animal AD models, the pro-inflammatory processes that start before the deposition of plaque and are facilitated by solubilized Aβ oligomers impede the NGF metabolic pathway, which is linked to a delayed transition of precursor pro-NGF to mature NGF [22]. The gene discussed is NGF; the disease is Alzheimer disease.